News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SEMPRUS BioSciences Closes $18 Million Series B Round



12/13/2010 7:11:46 AM

Mass High Tech -- Cambridge-based biomedical company focused on antibacterial coatings Semprus BioSciences Inc. has closed on an $18 million Series B financing round, led by SR One, the corporate venture capital arm of GlaxoSmithKline, and Foundation Medical Partners. According to Semprus officials, 5AM Ventures and Pangaea Ventures, both of whom invested in the company’s Series A financing, participated in the Series B round.

Read at Boston Globe
Read at Mass High Tech
Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES